Viewing Study NCT06641791



Ignite Creation Date: 2024-10-26 @ 3:42 PM
Last Modification Date: 2024-10-26 @ 3:42 PM
Study NCT ID: NCT06641791
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-10-09

Brief Title: Palliative Steroeotactic Body Radiotherapy vs Palliative Standard Radiotherapy in Patients With Advanced Head and Neck Cancer
Sponsor: None
Organization: None

Study Overview

Official Title: A Phase III Randomized Controlled Trial Comparing Palliative Stereotactic Body Radiotherapy vs Palliative Standard Radiotherapy in Patients With Advanced Head and Neck Cancer
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study is being done to answer the following question Does stereotactic body radiation therapy SBRT provide better cancer control compared to standard radiation therapy RT for those with advanced head and neck cancer
Detailed Description: Stereotactic body radiation therapy or SBRT is a cancer treatment that more precisely delivers radiation to the tumour area with less radiation going to unaffected areas around the tumour It uses fewer treatments of higher doses compared to standard radiation therapy

This study is being done to find out if this approach is better than the usual approach for advanced head and neck cancer The usual approach is defined as care most people get for advanced head and neck cancer

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None